Related Experiment Videos
Clinical pharmacy education in China
Melody Ryan1, Hong Shao, Li Yang
1University of Kentucky College of Pharmacy, USA.
American Journal of Pharmaceutical Education
|March 28, 2009
Summary
Chinese pharmacy education is shifting from traditional pharmaceutical sciences to clinical pharmacy. New master's or doctoral degrees in clinical pharmacy are being considered to meet evolving practice demands.
Area of Science:
- Pharmaceutical Sciences
- Clinical Pharmacy
- Pharmacy Education
Background:
- Traditional pharmacy education in China emphasizes pharmaceutical sciences with a Bachelor of Science (BS) as the entry-level degree.
- Curricula focus on compounding, dispensing, administration, and laboratory work, reflecting historical pharmacist roles.
- Graduate studies (Master of Science, Doctor of Philosophy) primarily concentrate on drug discovery and development.
Purpose of the Study:
- To describe the current state of pharmacy education in China.
- To highlight the emerging shift towards clinical pharmacy practice.
- To discuss the development of new degree programs and training to meet this demand.
Main Methods:
- Review of current pharmacy curricula and degree structures in China.
- Analysis of the evolving emphasis in pharmacy practice towards clinical roles.
- Examination of proposals for new professional degree offerings.
Main Results:
- The traditional BS in Pharmacy program focuses on foundational pharmaceutical sciences.
- Graduate programs (MS, PhD) are research-oriented in drug discovery and development.
- There is a growing demand for clinical pharmacists, prompting curriculum changes and new degree considerations.
- Non-degree training for clinical skills is also gaining interest.
Conclusions:
- Pharmacy education in China is adapting to a paradigm shift towards clinical pharmacy.
- New professional master's and doctoral degrees in clinical pharmacy are under consideration.
- These changes aim to equip pharmacists with advanced clinical skills to meet contemporary healthcare needs.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:06Three-Compartment Open Model
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...